The shale drillers are combining in an all-stock merger of equals, creating an entity with a combined market value of about $6 billion. The move could help them weather the prolonged slump in oil demand amid the Covid-19 pandemic
Read More »Gilead Nears Deal to Buy Immunomedics for More Than $20 Billion
The biotech drugmaker has a market value of roughly $10 billion, meaning that Gilead would be paying up for the company and its prized breast-cancer drug.
Read More »